Search Results for: FGFR1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
FLRT3 fibronectin leucine rich transmembrane protein 3
  • Signaling by ROBO receptors
  • Downstream signaling of activated FGFR1
FRS2 fibroblast growth factor receptor substrate 2
  • PI3K Cascade
  • PIP3 activates AKT signaling
  • Frs2-mediated activation
  • Frs2-mediated activation
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • PI-3K cascade:FGFR1
  • FRS-mediated FGFR1 signaling
  • PI-3K cascade:FGFR2
  • FRS-mediated FGFR2 signaling
  • FRS-mediated FGFR3 signaling
  • PI-3K cascade:FGFR3
  • FRS-mediated FGFR4 signaling
  • PI-3K cascade:FGFR4
  • Negative regulation of FGFR1 signaling
  • Negative regulation of FGFR2 signaling
  • Negative regulation of FGFR3 signaling
  • Negative regulation of FGFR4 signaling
  • Signaling by FGFR2 in disease
  • Signaling by FGFR4 in disease
  • Signaling by FGFR1 in disease
  • RAF/MAP kinase cascade
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • Signaling by FGFR3 fusions in cancer
  • Signaling by FGFR3 point mutants in cancer
  • RET signaling
  • Activated NTRK2 signals through FRS2 and FRS3
  • Activated NTRK2 signals through FRS2 and FRS3
FRS3 fibroblast growth factor receptor substrate 3
  • FRS-mediated FGFR1 signaling
  • FRS-mediated FGFR2 signaling
  • FRS-mediated FGFR3 signaling
  • FRS-mediated FGFR4 signaling
  • RAF/MAP kinase cascade
  • Activated NTRK2 signals through FRS2 and FRS3
GRB14 growth factor receptor bound protein 14
  • Tie2 Signaling
GRB2 growth factor receptor bound protein 2
  • Interleukin-15 signaling
  • Interleukin-15 signaling
  • STAT5 activation downstream of FLT3 ITD mutants
  • Signaling by FLT3 ITD and TKD mutants
  • Signaling by FLT3 ITD and TKD mutants
  • Pegademase
  • 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid
HTR1A 5-hydroxytryptamine receptor 1A
  • Serotonin receptors
  • Eletriptan
  • Ziprasidone
  • Methysergide
  • Cabergoline
  • Zolmitriptan
  • Amitriptyline
  • Olanzapine
  • Clozapine
  • Loxapine
  • Pramipexole
  • Methylphenidate
  • Imipramine
  • Chlorpromazine
  • Buspirone
  • Haloperidol
  • Nortriptyline
  • Amoxapine
  • Propranolol
  • Fenfluramine
  • Lisuride
  • Trazodone
  • Sumatriptan
  • Ergotamine
  • Apomorphine
  • Paroxetine
  • Trimipramine
  • Risperidone
  • Alprenolol
  • Ondansetron
  • Naratriptan
  • Pindolol
  • Dopamine
  • Ergoloid mesylate
  • Doxepin
  • Nefazodone
  • Desipramine
  • Escitalopram
  • Pergolide
  • Bromocriptine
  • Ketamine
  • Quetiapine
  • Aripiprazole
  • Chlorprothixene
  • Paliperidone
  • Penbutolol
  • Yohimbine
  • Acepromazine
  • Alverine
  • Molindone
  • Pipotiazine
  • Thioproperazine
  • Lysergic acid diethylamide
  • Dapoxetine
  • Bifeprunox
  • Flibanserin
  • Iloperidone
  • Lofexidine
  • Lesopitron
  • Rotigotine
  • MN-305
  • LI-301
  • Naluzotan
  • Cariprazine
  • Mianserin
  • Pizotifen
  • Asenapine
  • Xaliproden
  • Dotarizine
  • Sarizotan
  • Repinotan
  • Robalzotan
  • Vilazodone
  • Bopindolol
  • Cinitapride
  • Lurasidone
  • Perospirone
  • Cannabidiol
  • Vortioxetine
  • Brexpiprazole
  • Dosulepin
  • Pirlindole
  • Tianeptine
  • Setiptiline
  • Dihydroergocornine
  • Tetrahydrocannabivarin
  • Pardoprunox
  • Gilteritinib
  • Tiapride
  • Dihydroergocristine
  • Medical Cannabis
  • 5-methoxy-N,N-dimethyltryptamine
  • Nabiximols
  • Aripiprazole lauroxil
  • SEP-363856
HULC hepatocellular carcinoma up-regulated long non-coding RNA
IL17RD interleukin 17 receptor D
  • MAP2K and MAPK activation
ITK IL2 inducible T cell kinase
  • Generation of second messenger molecules
  • FCERI mediated Ca+2 mobilization
  • FCERI mediated Ca+2 mobilization
  • Staurosporine
  • Pazopanib
  • Fostamatinib
  • Zanubrutinib
KLB klotho beta
  • PI3K Cascade
  • PIP3 activates AKT signaling
  • betaKlotho-mediated ligand binding
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Phospholipase C-mediated cascade; FGFR4
  • FRS-mediated FGFR4 signaling
  • SHC-mediated cascade:FGFR4
  • PI-3K cascade:FGFR4
  • Negative regulation of FGFR4 signaling
  • RAF/MAP kinase cascade
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
KPNB1 karyopherin subunit beta 1
  • ISG15 antiviral mechanism
  • Apoptosis induced DNA fragmentation
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Transport of Ribonucleoproteins into the Host Nucleus
  • NS1 Mediated Effects on Host Pathways
  • Nuclear import of Rev protein
  • Nuclear import of Rev protein
  • Initiation of Nuclear Envelope (NE) Reformation
  • Neutrophil degranulation
  • Postmitotic nuclear pore complex (NPC) reformation
  • Inhibition of nitric oxide production
LDHA lactate dehydrogenase A
  • Pyruvate metabolism
  • NADH
  • Etheno-NAD
  • Nicotinamide
  • Oxamic Acid
  • Stiripentol
  • Copper
  • Artenimol
MFHAS1 malignant fibrous histiocytoma amplified sequence 1
NCAM1 neural cell adhesion molecule 1
  • ECM proteoglycans
  • NCAM signaling for neurite out-growth
  • NCAM signaling for neurite out-growth
  • NCAM1 interactions
  • NCAM1 interactions
  • Signal transduction by L1
  • RAF/MAP kinase cascade
  • Interferon gamma signaling
NCK1 NCK adaptor protein 1
  • Downstream signal transduction
  • Generation of second messenger molecules
  • Regulation of actin dynamics for phagocytic cup formation
  • Regulation of actin dynamics for phagocytic cup formation
  • Nephrin family interactions
  • DCC mediated attractive signaling
  • DCC mediated attractive signaling
  • Activation of RAC1
  • VEGFA-VEGFR2 Pathway
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate WASPs and WAVEs
  • FCGR3A-mediated phagocytosis
  • FCGR3A-mediated phagocytosis
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
NCK2 NCK adaptor protein 2
  • Downstream signal transduction
  • Nephrin family interactions
  • Ephrin signaling
  • Activation of RAC1
  • VEGFA-VEGFR2 Pathway
  • Regulation of cortical dendrite branching
NEDD4 NEDD4 E3 ubiquitin protein ligase
  • ISG15 antiviral mechanism
  • Downregulation of ERBB4 signaling
  • Regulation of PTEN localization
  • Regulation of PTEN stability and activity
  • Antigen processing: Ubiquitination & Proteasome degradation
NRP1 neuropilin 1
  • Neurophilin interactions with VEGF and VEGFR
  • Signaling by ROBO receptors
  • Sema3A PAK dependent Axon repulsion
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • CRMPs in Sema3A signaling
  • CRMPs in Sema3A signaling
  • Signal transduction by L1
  • CHL1 interactions
PDK1 pyruvate dehydrogenase kinase 1
  • Regulation of pyruvate dehydrogenase (PDH) complex
  • Signaling by Retinoic Acid
  • 4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE
  • Dichloroacetic acid
PIK3R1 phosphoinositide-3-kinase regulatory subunit 1
  • PI3K Cascade
  • IRS-mediated signalling
  • GPVI-mediated activation cascade
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • PI3K events in ERBB4 signaling
  • PIP3 activates AKT signaling
  • Interleukin-7 signaling
  • Interleukin-7 signaling
  • Signaling by SCF-KIT
  • Synthesis of PIPs at the plasma membrane
  • GAB1 signalosome
  • Signaling by cytosolic FGFR1 fusion mutants
  • Downstream signal transduction
  • PI3K events in ERBB2 signaling
  • PI3K/AKT activation
  • Downstream TCR signaling
  • Role of phospholipids in phagocytosis
  • Tie2 Signaling
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • DAP12 signaling
  • Role of LAT2/NTAL/LAB on calcium mobilization
  • Nephrin family interactions
  • Costimulation by the CD28 family
  • CD28 dependent PI3K/Akt signaling
  • G alpha (q) signalling events
  • GP1b-IX-V activation signalling
  • VEGFA-VEGFR2 Pathway
  • VEGFA-VEGFR2 Pathway
  • Interleukin-3, Interleukin-5 and GM-CSF signaling
  • Constitutive Signaling by EGFRvIII
  • PI-3K cascade:FGFR1
  • PI-3K cascade:FGFR2
  • PI-3K cascade:FGFR3
  • PI-3K cascade:FGFR4
  • Signaling by FGFR2 in disease
  • Signaling by FGFR4 in disease
  • Signaling by FGFR1 in disease
  • RAF/MAP kinase cascade
  • Interleukin-4 and Interleukin-13 signaling
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • MET activates PI3K/AKT signaling
  • Signaling by FGFR3 fusions in cancer
  • Signaling by FGFR3 point mutants in cancer
  • RET signaling
  • Extra-nuclear estrogen signaling
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
  • Activated NTRK2 signals through PI3K
  • Interleukin receptor SHC signaling
  • Regulation of signaling by CBL
  • Regulation of signaling by CBL
  • Activated NTRK3 signals through PI3K
  • FLT3 Signaling
  • FLT3 Signaling
  • Signaling by ERBB2 KD Mutants
  • Signaling by ERBB2 ECD mutants
  • Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants
  • Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
  • Signaling by PDGFRA extracellular domain mutants
  • Signaling by FLT3 fusion proteins
  • Signaling by FLT3 fusion proteins
  • Signaling by FLT3 ITD and TKD mutants
  • Signaling by FLT3 ITD and TKD mutants
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Isoprenaline
  • SF1126
  • Enzastaurin
  • Wortmannin

Page 3 out of 4 pages